サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1777654

迷走神経刺激の世界市場

Vagus Nerve Stimulation

出版日
ページ情報
英文 476 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
迷走神経刺激の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 476 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

迷走神経刺激の世界市場は2030年までに8億5,920万米ドルに達する見込み

2024年に5億1,570万米ドルと推定される迷走神経刺激の世界市場は、2030年には8億5,920万米ドルに達し、分析期間2024-2030年のCAGRは8.9%で成長すると予測されます。本レポートで分析したセグメントの1つである植え込み型VNS装置は、CAGR 7.7%を記録し、分析期間終了時には5億4,860万米ドルに達すると予測されます。体外式VNS装置セグメントの成長率は、分析期間でCAGR 11.2%と推定されます。

米国市場は1億4,050万米ドル、中国はCAGR12.0％で成長すると予測

米国の迷走神経刺激市場は、2024年に1億4,050万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億7,130万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.4%と7.7%と予測されています。欧州では、ドイツがCAGR約6.9%で成長すると予測されています。

世界の迷走神経刺激市場- 主要動向と促進要因のまとめ

迷走神経刺激がニューロモジュレーションのブレークスルーの最前線にあるのはなぜか？

迷走神経刺激（VNS）は、複雑な神経学的および精神医学的疾患の治療に希望をもたらす、神経調節の広範な分野における革新的なアプローチとして、近年重要な勢いを増しています。当初は難治性てんかんの治療薬として承認されたが、その後、VNSは治療抵抗性うつ病、片頭痛、群発頭痛、さらには炎症性疾患や心疾患への応用など、その治療範囲を拡大しています。このように臨床の多様性が増しているのは、迷走神経が自律神経系全体に広範な生理的影響を及ぼし、VNSが脳回路、神経伝達物質の放出、および炎症経路を調節することを可能にしているからです。最新のVNS装置には、植え込み型と非侵襲型のシステムがあり、経皮的VNS（tVNS）は、その使いやすさと手技リスクの軽減から支持を集めています。経皮的VNSは、手術用リード線または耳や頸部の電極を介して、迷走神経に制御された電気インパルスを供給します。従来の治療に代わる、薬物を使用しない長期的な治療法を求める患者が増加する中、VNSは、特に慢性的で治療抵抗性の疾患において、実行可能な解決策として浮上してきました。臨床的エビデンスが増えるにつれて、より多くの医師が集学的治療モデルにVNSを組み込むようになり、治療適応の拡大とともに患者の関心も高まっています。この変化は、個別化された神経標的医療の柱として、VNSの重要性が高まっていることを強調しています。

技術革新は、VNS装置の有効性とアクセシビリティをどのように高めていますか？

技術の進歩は、迷走神経刺激デバイスの能力と到達範囲を再定義する上で、決定的な役割を果たしています。最新世代の植え込み型VNSシステムは、心拍数や脳波データなどの生理学的マーカーに基づいて電気パルスをリアルタイムに適応させる、応答型またはクローズドループ型の刺激を特徴としています。このようなインテリジェントな装置は、患者のアドヒアランスにとって重要な要素である副作用を最小限に抑えながら、治療結果を改善します。非侵襲的な選択肢、特にtVNSウェアラブルは、治療スケジュールの柔軟性を導入し、手術の必要性を減らし、自宅での治療を可能にしました。バッテリー寿命、デバイスのプログラマビリティ、小型化も大幅に改善され、ユーザーの快適性と利便性の向上に寄与しています。モバイル・アプリケーションやクラウドベースの分析機能との統合により、遠隔モニタリング、臨床医によるフィードバック、個別化された投与レジメンが可能になり、継続的ケア・モデルの扉が開かれました。VNSプラットフォームの中には、患者固有の反応に基づいて治療パラメーターを微調整する機械学習アルゴリズムを模索しているものもあります。さらに、デジタルメンタルヘルスツールや睡眠モニタリングアプリなど、他の医療技術との相互運用性により、より総合的な患者サポートが可能になりつつあります。これらの技術革新により、VNSは高度に専門化された病院ベースの治療から、外来患者および遠隔医療環境の両方において関連性が高まる、より広範で適応性の高いソリューションへと変化しつつあります。

市場成熟において薬事承認と調査パイプラインはどのような役割を果たすか？

迷走神経刺激を取り巻く規制や臨床試験の状況は急速に進化しており、信頼性の向上、検証、商業化の機会を通じて市場の拡大を促進しています。米国FDAと欧州CEマーク当局は、さまざまな適応症におけるVNS機器の承認を拡大し、既存医療技術企業と新興企業のイノベーションを促進しています。たとえば、非侵襲性VNS装置は頭痛障害で市場参入を果たし、PTSDや炎症性腸疾患などの症状で画期的医療機器指定を受けた。これらのマイルストーンは、有効性と安全性を証明するだけでなく、さらなる開発のための加速的な道筋をサポートするものです。同時に、耳鳴り、線維筋痛症、不安、関節リウマチ、さらにはアルツハイマー病に関連する認知機能低下などの疾患におけるVNSの応用が、強力な臨床試験のパイプラインによって検討されています。このように潜在的な用途のポートフォリオが拡大していることは、VNS療法の適応性を強調するものであり、投資家、ヘルスケアプロバイダー、患者に対するVNSの価値提案を高めるものです。神経調節研究のための公的・民間資金も増加しており、バイオエレクトロニック・インプラントや遺伝子調節神経インターフェイスなど、次世代VNS導入メカニズムの探求を目的とした産学共同研究に拍車をかけています。このような開発が進むにつれて、得られたデータは、臨床ガイドラインにおけるVNSの役割を確固としたものにし、償還の枠組みの拡大を促し、市場の採用をさらに刺激することになるでしょう。

迷走神経刺激ソリューションの世界需要を牽引する要因とは？

迷走神経刺激市場の成長は、技術の進歩、治療の多様化、治療パラダイムの変化、患者エンゲージメントの増加に直結するいくつかの要因によって牽引されています。てんかんやうつ病のような神経疾患の世界の罹患率の上昇-特に高齢化と治療抵抗性人口の間で-は、薬理学的負担なしに長期的な緩和を提供する代替療法への持続的な需要を生み出しています。非侵襲的なVNS装置の利用可能性と受容性の拡大により、患者や医療提供者の参入障壁が下がり、外来患者や在宅医療の現場での導入に拍車がかかっています。生体電子医学や、炎症、ストレス、気分における迷走神経の調節的役割に対する認識の高まりも、臨床と健康の両面から新たな関心を集めています。ヘルスケアシステムや保険会社は、特に慢性的な投薬や入院の費用が高額になるケースにおいて、費用対効果の高い介入として神経調節に徐々に同調しつつあります。さらに、個別化医療の動向とデジタルヘルスツールの統合により、患者はより積極的に治療を管理できるようになり、VNSプラットフォームはリアルタイムデータと適応治療を提供するようになってきています。医療技術企業の急速な技術革新は、有利な規制指定や神経技術研究への投資の増加と相まって、北米、欧州、そしてアジア太平洋のような急速に研究開発が進んでいる地域に市場の足跡を広げています。これらの動きを総合すると、VNSは世界の治療状況において、強力で拡張可能なソリューションとして位置づけられています。

セグメント

製品（植え込み型VNS装置、外部VNS装置）、生体材料（金属、セラミック、ポリマー）、用途（てんかん、うつ病、片頭痛）、最終用途（病院、神経科クリニック、外来手術センター、研究センター）

調査対象企業の例

  • BioControl Medical
  • Boston Scientific Corporation
  • Cirtec Medical
  • Cyberonics, Inc.
  • electroCore, Inc.
  • Endonovo Therapeutics, Inc.
  • EnteroMedics Inc.
  • Helius Medical Technologies, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova PLC
  • Masimo Corporation
  • Medtronic plc
  • MicroTransponder Inc.
  • Nevro Corp.
  • NeuroMetrix, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Parasym Ltd
  • SetPoint Medical Corporation
  • tVNS Health GmbH

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP33223

Global Vagus Nerve Stimulation Market to Reach US$859.2 Million by 2030

The global market for Vagus Nerve Stimulation estimated at US$515.7 Million in the year 2024, is expected to reach US$859.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Implantable VNS Device, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$548.6 Million by the end of the analysis period. Growth in the External VNS Device segment is estimated at 11.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$140.5 Million While China is Forecast to Grow at 12.0% CAGR

The Vagus Nerve Stimulation market in the U.S. is estimated at US$140.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$171.3 Million by the year 2030 trailing a CAGR of 12.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Vagus Nerve Stimulation Market - Key Trends & Drivers Summarized

Why Is Vagus Nerve Stimulation at the Forefront of Neuromodulation Breakthroughs?

Vagus nerve stimulation (VNS) has gained critical momentum in recent years as a transformative approach within the broader field of neuromodulation, offering hope in the treatment of complex neurological and psychiatric conditions. Originally approved for refractory epilepsy, VNS has since expanded its therapeutic reach to include treatment-resistant depression, migraine, cluster headaches, and even promising applications in inflammatory diseases and cardiac disorders. This growing clinical versatility stems from the vagus nerve’s extensive physiological influence across the autonomic nervous system, enabling VNS to modulate brain circuits, neurotransmitter release, and inflammatory pathways. Modern VNS devices include both implantable and non-invasive systems, with transcutaneous VNS (tVNS) gaining favor for its ease of use and reduced procedural risks. These devices deliver controlled electrical impulses to the vagus nerve, either via surgical leads or external ear or neck-based electrodes. With an increasing number of patients seeking drug-free, long-term alternatives to conventional treatments, VNS has emerged as a viable solution, particularly in chronic and treatment-resistant conditions. As the body of clinical evidence grows, more physicians are integrating VNS into multidisciplinary care models, and patient interest is rising in parallel with expanded therapeutic indications. This shift underscores the growing importance of VNS as a pillar of personalized, neuro-targeted medicine.

How Are Technological Innovations Enhancing the Efficacy and Accessibility of VNS Devices?

Technological advancements are playing a decisive role in redefining the capabilities and reach of vagus nerve stimulation devices. The latest generation of implantable VNS systems now feature responsive or closed-loop stimulation, allowing real-time adaptation of electrical pulses based on physiological markers such as heart rate or electroencephalographic data. These intelligent devices improve therapeutic outcomes while minimizing side effects, a crucial factor in patient adherence. Non-invasive options, particularly tVNS wearables, have introduced flexibility in treatment schedules, reducing the need for surgery and enabling at-home therapy. Battery life, device programmability, and miniaturization have also seen significant improvements, contributing to enhanced comfort and convenience for users. Integration with mobile applications and cloud-based analytics allows remote monitoring, clinician feedback, and individualized dosing regimens, opening doors for continuous care models. Some VNS platforms are exploring machine learning algorithms to fine-tune therapy parameters based on patient-specific responses. Additionally, device interoperability with other health technologies, such as digital mental health tools or sleep monitoring apps, is enabling more holistic patient support. These innovations are transforming VNS from a highly specialized hospital-based therapy into a broader, more adaptable solution with growing relevance in both outpatient and telehealth environments.

What Role Do Regulatory Approvals and Research Pipelines Play in Market Maturation?

The regulatory and clinical trial landscape surrounding vagus nerve stimulation is rapidly evolving, fostering market expansion through increased trust, validation, and commercialization opportunities. The U.S. FDA and European CE Mark authorities have broadened approval for VNS devices across various indications, encouraging innovation among both established medtech companies and start-ups. For instance, non-invasive VNS devices have gained market entry for headache disorders and have received Breakthrough Device Designation for conditions such as PTSD and inflammatory bowel disease. These milestones not only validate efficacy and safety but also support accelerated pathways for further development. Concurrently, a robust pipeline of clinical trials is exploring VNS applications in disorders such as tinnitus, fibromyalgia, anxiety, rheumatoid arthritis, and even cognitive decline linked to Alzheimer's disease. This expanding portfolio of potential uses underscores the adaptability of VNS therapy and enhances its value proposition to investors, healthcare providers, and patients. Public and private funding for neuromodulation research is also growing, fueling academic-industry collaborations aimed at exploring next-gen VNS delivery mechanisms, including bioelectronic implants and gene-modulated neural interfaces. As these developments continue, the resulting data will solidify the role of VNS in clinical guidelines and encourage reimbursement frameworks to widen, further stimulating market adoption.

What Factors Are Driving the Global Demand for Vagus Nerve Stimulation Solutions?

The growth in the vagus nerve stimulation market is driven by several factors directly linked to technological advancements, therapeutic diversification, changing treatment paradigms, and increasing patient engagement. The rising global incidence of neurological disorders such as epilepsy and depression-especially among aging and treatment-resistant populations-is creating sustained demand for alternative therapies that offer long-term relief without pharmacological burden. The expanding availability and acceptance of non-invasive VNS devices have lowered the entry barrier for patients and providers alike, fueling adoption across outpatient and home care settings. Increased awareness of bioelectronic medicine and the vagus nerve’s regulatory role in inflammation, stress, and mood is also attracting new interest from both clinical and wellness perspectives. Healthcare systems and insurers are gradually aligning with neuromodulation as a cost-effective intervention, especially in cases where chronic medication and hospitalization costs are high. Furthermore, personalized medicine trends and the integration of digital health tools are empowering patients to manage their treatment more proactively, with VNS platforms increasingly offering real-time data and adaptive therapy. Rapid innovation from medtech companies, combined with favorable regulatory designations and growing investment in neurotechnology research, is expanding the market footprint across North America, Europe, and rapidly developing regions like Asia-Pacific. Collectively, these dynamics are positioning VNS as a powerful, scalable solution within the global therapeutic landscape.

SCOPE OF STUDY:

The report analyzes the Vagus Nerve Stimulation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable VNS Device, External VNS Device); Biomaterial (Metallic, Ceramics, Polymeric); Application (Epilepsy, Depression, Migraine); End-Use (Hospitals, Neurology Clinics, Ambulatory Surgery Centers, Research Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • BioControl Medical
  • Boston Scientific Corporation
  • Cirtec Medical
  • Cyberonics, Inc.
  • electroCore, Inc.
  • Endonovo Therapeutics, Inc.
  • EnteroMedics Inc.
  • Helius Medical Technologies, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova PLC
  • Masimo Corporation
  • Medtronic plc
  • MicroTransponder Inc.
  • Nevro Corp.
  • NeuroMetrix, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Parasym Ltd
  • SetPoint Medical Corporation
  • tVNS Health GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vagus Nerve Stimulation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Neurological and Psychiatric Disorders Drives Demand for Vagus Nerve Stimulation Therapies
    • Expansion of Non-Invasive VNS Devices Spurs Growth in At-Home and Outpatient Treatment Adoption
    • Advancements in Closed-Loop and Responsive Stimulation Technologies Strengthen the Business Case for Smart VNS Systems
    • FDA Approvals and Breakthrough Device Designations Propel Market Expansion Across New Therapeutic Indications
    • Growing Use of VNS in Treatment-Resistant Depression and Epilepsy Sustains Long-Term Market Growth
    • Integration of VNS With Wearables and Mobile Health Apps Generates Opportunities for Remote Monitoring Solutions
    • Increased Focus on Bioelectronic Medicine Throws the Spotlight on VNS as a Pillar of Neuromodulation Therapies
    • Consumer Preference for Drug-Free Chronic Condition Management Drives Adoption of Implant-Free VNS Alternatives
    • Emerging Applications in Cognitive Health and PTSD Generate Demand for Specialized VNS Protocols
    • Increasing Awareness of the Gut-Brain Axis and Autonomic Nervous System Function Enhances Interest in VNS Therapies
    • Global Aging Population and Rise in Neurodegenerative Diseases Create Sustainable Demand for VNS Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vagus Nerve Stimulation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Implantable VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Implantable VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for External VNS Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for External VNS Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Neurology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Metallic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ceramics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ceramics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Polymeric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Polymeric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • JAPAN
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • CHINA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • EUROPE
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Vagus Nerve Stimulation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • FRANCE
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • GERMANY
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: UK 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Spain 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Spain 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Russia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Russia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Europe 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Australia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Australia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • INDIA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 215: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: India 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: India 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: South Korea 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Vagus Nerve Stimulation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Argentina 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Brazil 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Mexico 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Latin America 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Vagus Nerve Stimulation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Iran 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Iran 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Israel 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Israel 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: Saudi Arabia 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: UAE Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: UAE 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: UAE Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: UAE 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Rest of Middle East 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030
  • AFRICA
    • Vagus Nerve Stimulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Vagus Nerve Stimulation by Product - Implantable VNS Device and External VNS Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Vagus Nerve Stimulation by Product - Percentage Breakdown of Value Sales for Implantable VNS Device and External VNS Device for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Vagus Nerve Stimulation by End-Use - Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Vagus Nerve Stimulation by End-Use - Percentage Breakdown of Value Sales for Neurology Clinics, Ambulatory Surgery Centers, Research Centers and Hospitals for the Years 2015, 2025 & 2030
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Africa Historic Review for Vagus Nerve Stimulation by Biomaterial - Metallic, Ceramics and Polymeric Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 397: Africa 15-Year Perspective for Vagus Nerve Stimulation by Biomaterial - Percentage Breakdown of Value Sales for Metallic, Ceramics and Polymeric for the Years 2015, 2025 & 2030
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Africa Historic Review for Vagus Nerve Stimulation by Application - Epilepsy, Depression and Migraine Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 400: Africa 15-Year Perspective for Vagus Nerve Stimulation by Application - Percentage Breakdown of Value Sales for Epilepsy, Depression and Migraine for the Years 2015, 2025 & 2030

IV. COMPETITION